coversyl arginine 5 mg film-coated tablets
pco manufacturing ltd. - perindopril arginine - film-coated tablet - 5 milligram(s) - ace inhibitors, plain; perindopril
maximum strength acid reducer without prescription tablet
pharmascience inc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists
acid reducer tablet
pharmascience inc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists
pravastatin sodium 40 milligram tablets
actavis group ptc ehf - pravastatin sodium - tablets - 40 milligram - hmg coa reductase inhibitors
pravastatin sodium 10 milligram tablets
actavis group ptc ehf - pravastatin sodium - tablets - 10 milligram - hmg coa reductase inhibitors
pravastatin sodium 20 milligram tablets
actavis group ptc ehf - pravastatin sodium - tablets - 20 milligram - hmg coa reductase inhibitors
pravastatin sodium 10mg tablets
milpharm limited - pravastatin sodium - tablets - 10mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors
pravastatin sodium 20mg tablets
milpharm limited - pravastatin sodium - tablets - 20mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors
pravastatin sodium 40mg tablets
milpharm limited - pravastatin sodium - tablets - 40mg - serum lipid reducing agents/cholesterol and triglyceride reducers/hmg-coa reductase inhibitors - treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate; reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet; reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors
acid reducer tablet
mylan pharmaceuticals ulc - ranitidine (ranitidine hydrochloride) - tablet - 75mg - ranitidine (ranitidine hydrochloride) 75mg - histamine h2-antagonists